{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T14:32:49Z","timestamp":1787149969960,"version":"build-2736575974"},"reference-count":84,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Cancer epitopes, the molecular structures recognized by T and B cells at the tumor interface, are central to understanding antitumor immunity and developing immunotherapies. Yet despite the rapid growth of cancer immunology data, a comprehensive, continuously updated, and accessible resource for cancer epitope data has been lacking. The Cancer Epitope Database and Analysis Resource (CEDAR, cedar.iedb.org) was established in 2021 to fill this gap, providing curated experimental epitope data alongside a suite of cancer-specific computational tools for epitope prediction and analysis. Built on the validated infrastructure of the Immune Epitope Database (IEDB), CEDAR integrates cancer epitope data with biological, immunological, and clinical context, enabling researchers to explore immune recognition of tumors, identify candidate targets for immunotherapy, and benchmark prediction methods. Here we describe CEDAR\u2019s current capabilities, report on progress in curation, database development, and tool availability, and outline the opportunities and challenges ahead for expanding its scope and utility to the cancer research community.<\/jats:p>","DOI":"10.3389\/fonc.2026.1898826","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T14:10:06Z","timestamp":1787148606000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The Cancer Epitope Database and Analysis Resource (CEDAR): current capabilities and future directions"],"prefix":"10.3389","volume":"16","author":[{"given":"Zeynep","family":"Ko\u015falo\u011flu-Yal\u00e7\u0131n","sequence":"first","affiliation":[{"name":"Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla","place":["CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibel","family":"Carri","sequence":"additional","affiliation":[{"name":"Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla","place":["CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Marrama","sequence":"additional","affiliation":[{"name":"Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla","place":["CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eve","family":"Richardson","sequence":"additional","affiliation":[{"name":"Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla","place":["CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Greenbaum","sequence":"additional","affiliation":[{"name":"Bioinformatics Core, La Jolla Institute for Immunology, La Jolla","place":["San Diego, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Blazseka","sequence":"additional","affiliation":[{"name":"Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla","place":["CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randi","family":"Vita","sequence":"additional","affiliation":[{"name":"Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla","place":["CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Carter","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, San Diego, La Jolla","place":["CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Department of Health Technology, Technical University of Denmark","place":["Lyngby, Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bjoern","family":"Peters","sequence":"additional","affiliation":[{"name":"Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla","place":["CA, United States"]},{"name":"Department of Medicine, University of California, San Diego, La Jolla","place":["CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Sette","sequence":"additional","affiliation":[{"name":"Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla","place":["CA, United States"]},{"name":"Department of Medicine, University of California, San Diego, La Jolla","place":["CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"4098","DOI":"10.1038\/s41467-021-24343-x","article-title":"The T cell receptor repertoire of tumor infiltrating T cells is predictive and prognostic for cancer survival","volume":"12","author":"Valpione","year":"2021","journal-title":"Nat Commun"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12092158","article-title":"Revolutionizing cancer treatment: Recent advances in immunotherapy","volume":"12","author":"Ghemrawi","year":"2024","journal-title":"Biomedicines"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-025-01152-6","article-title":"Clinical trials by the numbers","volume":"640","author":"Plackett","year":"2025","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231710131","article-title":"Sources of cancer neoantigens beyond single-nucleotide variants","volume":"23","author":"Capietto","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1126\/science.adk3487","article-title":"Pancreatic cancer-restricted cryptic antigens are targets for T cell recognition","volume":"388","author":"Ely","year":"2025","journal-title":"Science"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-024-02420-y","article-title":"A comprehensive proteogenomic pipeline for neoantigen discovery to advance personalized cancer immunotherapy","volume":"43","author":"Huber","year":"2025","journal-title":"Nat Biotechnol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1126\/science.abe6474","article-title":"Pan-cancer single-cell landscape of tumor-infiltrating T cells","volume":"374","author":"Zheng","year":"2021","journal-title":"Science"},{"key":"B8","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","article-title":"Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion","volume":"21","author":"Jhunjhunwala","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2024.09.010","article-title":"The hallmarks of cancer immune evasion","volume":"42","author":"Galassi","year":"2024","journal-title":"Cancer Cell"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2020.188464","article-title":"Altered glycosylation in cancer: A promising target for biomarkers and therapeutics","volume":"1875","author":"Thomas","year":"2021","journal-title":"Biochim Biophys Acta. Rev Cancer"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01270-x","article-title":"Neoantigens: promising targets for cancer therapy","volume":"8","author":"Xie","year":"2023","journal-title":"Signal Transd. Targ. Ther"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz452","article-title":"IEDB-AR: Immune epitope database-analysis resource in 2019","volume":"47","author":"Dhanda","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-3239-0_9","article-title":"IEDB and CEDAR: Two sibling databases to serve the global scientific community","volume":"2673","author":"Blazeska","year":"2023","journal-title":"Methods Mol Biol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkae1092","article-title":"The immune epitope database (IEDB): 2024 update","volume":"53","author":"Vita","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/cfg.445","article-title":"Overview and utilization of the NCI thesaurus","volume":"5","author":"Fragoso","year":"2004","journal-title":"Comp Funct Genomics"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/database\/baab069","article-title":"OBO Foundry in 2021: operationalizing open data principles to evaluate ontologies","volume":"2021","author":"Jackson","year":"2021","journal-title":"Database (Oxford)"},{"key":"B17","unstructured":"Curation Manual 2.0\n          \n          2007"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/database\/bax105","article-title":"FAIR principles and the IEDB: short-term improvements and a long-term vision of OBO-foundry mediated machine-actionable interoperability","volume":"2018","author":"Vita","year":"2018","journal-title":"Database (Oxford)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13234","article-title":"A behind-the-scenes tour of the IEDB curation process: an optimized process empirically integrating automation and human curation efforts","volume":"161","author":"Salimi","year":"2020","journal-title":"Immunology"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkae407","article-title":"Next-generation IEDB tools: a platform for epitope prediction and analysis","volume":"52","author":"Yan","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkag457","article-title":"Cancer epitope prediction tools and analysis pipelines in CEDAR","author":"Carri","year":"2026","journal-title":"Nucleic Acids Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"735609","DOI":"10.3389\/fimmu.2021.735609","article-title":"The cancer epitope database and analysis resource: a blueprint for the establishment of a new bioinformatics resource for use by the cancer immunology community","volume":"12","author":"Ko\u015falo\u011flu-Yal\u00e7\u0131n","year":"2021","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac902","article-title":"The cancer epitope database and analysis resource (CEDAR)","volume":"51","author":"Ko\u015falo\u011flu-Yal\u00e7\u0131n","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1200\/cci.19.00132","article-title":"Integrated informatics analysis of cancer-related variants","volume":"4","author":"Pagel","year":"2020","journal-title":"JCO. Clin Cancer Inform"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkt1113","article-title":"ClinVar: public archive of relationships among sequence variation and human phenotype","volume":"42","author":"Landrum","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-021-01142-2","article-title":"TRUST4: immune repertoire reconstruction from bulk and single-cell RNA-seq data","volume":"18","author":"Song","year":"2021","journal-title":"Nat Methods"},{"key":"B27","first-page":"2026.01.08.698331","article-title":"Curation at scale with EPITOME: Extraction pipeline for immunological texts and open-source multimodal enquiry","volume-title":"Biorxiv.","author":"Richardson","year":"2026"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3774","article-title":"CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer","volume":"49","author":"Griffith","year":"2017","journal-title":"Nat Genet"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21254-9","article-title":"The NCI genomic data commons","volume":"53","author":"Heath","year":"2021","journal-title":"Nat Genet"},{"key":"B31","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12859-021-03962-7","article-title":"TANTIGEN 2.0: a knowledge base of tumor T cell antigens and epitopes","volume":"22","author":"Zhang","year":"2021","journal-title":"BMC Bioinf"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.644637","article-title":"NEPdb: A database of T-cell experimentally-validated neoantigens and pan-cancer predicted neoepitopes for cancer immunotherapy","volume":"12","author":"Xia","year":"2021","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/database\/baaa062","article-title":"NCBI Taxonomy: a comprehensive update on curation, resources and tools","volume":"2020","author":"Schoch","year":"2020","journal-title":"Database (Oxford)"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/75556","article-title":"Gene ontology: tool for the unification of biology. The Gene Ontology Consortium","volume":"25","author":"Ashburner","year":"2000","journal-title":"Nat Genet"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky1055","article-title":"The Gene Ontology Resource: 20 years and still GOing strong","volume":"47","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2764","article-title":"The Cancer Genome Atlas Pan-Cancer analysis project","volume":"45","author":"Weinstein","year":"2013","journal-title":"Nat Genet"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1186-3","article-title":"Next-generation characterization of the cancer cell line encyclopedia","volume":"569","author":"Ghandi","year":"2019","journal-title":"Nature"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhlen","year":"2015","journal-title":"Science"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0162-4","article-title":"Alternative tumour-specific antigens","volume":"19","author":"Smith","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2005-6-5-r44","article-title":"The Sequence Ontology: a tool for the unification of genome annotations","volume":"6","author":"Eilbeck","year":"2005","journal-title":"Genome Biol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkr407","article-title":"Predicting the functional impact of protein mutations: application to cancer genomics","volume":"39","author":"Reva","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gks1067","article-title":"New and continuing developments at PROSITE","volume":"41","author":"Sigrist","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1101\/311209","article-title":"NetSurfP-2.0: Improved prediction of protein structural features by integrated deep learning","volume":"87","author":"Klausen","year":"2019","journal-title":"Proteins"},{"key":"B44","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cels.2019.05.005","article-title":"CHASMplus reveals the scope of somatic missense mutations driving human cancers","volume":"9","author":"Tokheim","year":"2019","journal-title":"Cell Syst"},{"key":"B45","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s00262-025-04209-7","article-title":"A meta-analysis of experimentally validated neo-epitopes: patterns, biases, and opportunities","volume":"74","author":"Sette","year":"2025","journal-title":"Cancer Immunol. Immunother"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.0020125","article-title":"The biocurator: connecting and enhancing scientific data","volume":"2","author":"Salimi","year":"2006","journal-title":"PloS Comput Biol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-7-341","article-title":"Curation of complex, context-dependent immunological data","volume":"7","author":"Vita","year":"2006","journal-title":"BMC Bioinf"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.a.20585","article-title":"The curation guidelines of the immune epitope database and analysis resource","volume":"73","author":"Vita","year":"2008","journal-title":"Cytometry. A"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/5974574","article-title":"The Immune Epitope Database: How data are entered and retrieved","volume":"2017","author":"Fleri","year":"2017","journal-title":"J Immunol Res"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02688","article-title":"Epitope specific antibodies and T cell receptors in the Immune Epitope Database","volume":"9","author":"Mahajan","year":"2018","journal-title":"Front Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006948","article-title":"Classification of the universe of immune epitope literature: representation and knowledge gaps","volume":"4","author":"Davies","year":"2009","journal-title":"PloS One"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-482","article-title":"Cost sensitive hierarchical document classification to triage PubMed abstracts for manual curation","volume":"12","author":"Seymour","year":"2011","journal-title":"BMC Bioinf"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1093\/database\/bax014","article-title":"Better living through ontologies at the Immune Epitope Database","volume":"2017","author":"Vita","year":"2017","journal-title":"Database (Oxford)"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2023.08.145","article-title":"A meta-analysis of epitopes in prostate-specific antigens identifies opportunities and knowledge gaps","volume":"84","author":"Foos","year":"2023","journal-title":"Hum Immunol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.smim.2009.10.003","article-title":"Lipid and glycolipid antigens of CD1d-restricted natural killer T cells","volume":"22","author":"Venkataswamy","year":"2010","journal-title":"Semin Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3670","article-title":"Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy","volume":"14","author":"Coulie","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.cir-16-0280","article-title":"Identification of glycopeptides as posttranslationally modified neoantigens in leukemia","volume":"5","author":"Malaker","year":"2017","journal-title":"Cancer Immunol Res"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1649","article-title":"The sweet and sour of cancer: glycans as novel therapeutic targets","volume":"5","author":"Fuster","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12243","article-title":"Neoantigen-based cancer vaccination using chimeric RNA-loaded dendritic cell-derived extracellular vesicles","volume":"11","author":"Xiong","year":"2022","journal-title":"J Extracell. Vesicles"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-022-01464-2","article-title":"Post-translational modifications reshape the antigenic landscape of the MHC I immunopeptidome in tumors","volume":"41","author":"Kacen","year":"2023","journal-title":"Nat Biotechnol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abm6359","article-title":"Noncanonical splicing junctions between exons and transposable elements represent a source of immunogenic recurrent neo-antigens in patients with lung cancer","volume":"8","author":"Merlotti","year":"2023","journal-title":"Sci Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-023-01349-3","article-title":"Pan-cancer analysis identifies tumor-specific antigens derived from transposable elements","volume":"55","author":"Shah","year":"2023","journal-title":"Nat Genet"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1347542","article-title":"Untranslated regions (UTRs) are a potential novel source of neoantigens for personalised immunotherapy","volume":"15","author":"Sng","year":"2024","journal-title":"Front Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.103850","article-title":"Combined assessment of MHC binding and antigen abundance improves T cell epitope predictions","volume":"25","author":"Ko\u015falo\u011flu-Yal\u00e7\u0131n","year":"2022","journal-title":"iScience"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2023.1082168","article-title":"Estimating tissue-specific peptide abundance from public RNA-Seq data","volume":"14","author":"Frentzen","year":"2023","journal-title":"Front Genet"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.09.050","article-title":"MHC-I genotype restricts the oncogenic mutational landscape","volume":"171","author":"Marty","year":"2017","journal-title":"Cell"},{"key":"B67","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1186\/s12859-023-05606-4","article-title":"PEPMatch: a tool to identify short peptide sequence matches in large sets of proteins","volume":"24","author":"Marrama","year":"2023","journal-title":"BMC Bioinf"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.640725","article-title":"TCRMatch: Predicting T-cell receptor specificity based on sequence similarity to previously characterized receptors","volume":"12","author":"Chronister","year":"2021","journal-title":"Front Immunol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12984","article-title":"Development of a novel clustering tool for linear peptide sequences","volume":"155","author":"Dhanda","year":"2018","journal-title":"Immunology"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.2c02425","article-title":"Predicting the success of Fmoc-based peptide synthesis","volume":"7","author":"Gutman","year":"2022","journal-title":"ACS Omega"},{"key":"B71","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41541-025-01273-z","article-title":"Publisher correction: AI-driven epitope prediction: a systematic review, comparative analysis, and practical guide for vaccine development","volume":"10","author":"Villanueva-Flores","year":"2025","journal-title":"NPJ Vaccines"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-24-2553","article-title":"Leveraging artificial intelligence for neoantigen prediction","volume":"85","author":"Zeng","year":"2025","journal-title":"Cancer Res"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbaf302","article-title":"Computational methods and data resources for predicting tumor neoantigens","volume":"26","author":"Zhao","year":"2025","journal-title":"Brief Bioinform"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbac259","article-title":"A comprehensive analysis of the IEDB MHC class-I automated benchmark","volume":"23","author":"Trevizani","year":"2022","journal-title":"Brief Bioinform"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btx820","article-title":"An automated benchmarking platform for MHC class II binding prediction methods","volume":"34","author":"Andreatta","year":"2018","journal-title":"Bioinformatics"},{"key":"B76","unstructured":"Google Analytics\n          \n          2005"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.cir-19-0401","article-title":"pVACtools: A computational toolkit to identify and visualize cancer neoantigens","volume":"8","author":"Hundal","year":"2020","journal-title":"Cancer Immunol Res"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.am2026-lb161","article-title":"Abstract LB161: A comparative study of neoantigen discovery pipelines uncovers discrepancies in the generation of mutated neopeptide sequences","volume":"86","author":"Carri","year":"2026","journal-title":"Cancer Res"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.3c01667","article-title":"APE-Gen2.0: Expanding rapid class I peptide-major histocompatibility complex modeling to post-translational modifications and noncanonical peptide geometries","volume":"64","author":"Fasoulis","year":"2024","journal-title":"J Chem Inf. Model"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1101\/2025.04.07.647596","article-title":"A modular, immunopeptidogenomic (iPepGen) analysis pipeline for discovery, verification, and prioritization of cancer peptide neoantigen candidates","author":"Mehta","year":"2025","journal-title":"bioRxiv"},{"key":"B81","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/978-1-0716-4566-6_3","article-title":"Using the cancer epitope database and analysis resource (CEDAR)","volume":"2932","author":"Ko\u015falo\u011flu-Yal\u00e7\u0131n","year":"2025","journal-title":"Methods Mol Biol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0154556","article-title":"The ontology for biomedical investigations","volume":"11","author":"Bandrowski","year":"2016","journal-title":"PloS One"},{"key":"B83","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13326-016-0088-7","article-title":"The Cell Ontology 2016: enhanced content, modularization, and ontology interoperability","volume":"7","author":"Diehl","year":"2016","journal-title":"J BioMed Semantics"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2012-13-1-r5","article-title":"Uberon, an integrative multi-species anatomy ontology","volume":"13","author":"Mungall","year":"2012","journal-title":"Genome Biol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1898826\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T14:10:09Z","timestamp":1787148609000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1898826\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,19]]},"references-count":84,"alternative-id":["10.3389\/fonc.2026.1898826"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1898826","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,19]]},"article-number":"1898826"}}